Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-000233-41Phase 4Active
Phase 4, randomised, open-label trial of misoprostol (2 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Primary safety endpoint. Started Jul 2020; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-000233-41.